| scholarly article | Q13442814 |
| P50 | author | Jens Klotsche | Q56956627 |
| Hans-Ulrich Wittchen | Q1435357 | ||
| P2093 | author name string | Dorothee M Baur | |
| Stefanos N Kales | |||
| Christos S Mantzoros | |||
| Roland M Schmid | |||
| Günter K Stalla | |||
| Caroline Sievers | |||
| Lars Pieper | |||
| Ole-Petter R Hamnvik | |||
| P433 | issue | 10 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 1363-1371 | |
| P577 | publication date | 2010-11-16 | |
| P1433 | published in | Metabolism | Q15764354 |
| P1476 | title | Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort | |
| P478 | volume | 60 |
| Q34255016 | Akt and phospholipase Cγ are involved in the regulation of growth and migration of MDA-MB-468 breast cancer and SW480 colon cancer cells when cultured with diabetogenic levels of glucose and insulin |
| Q33646525 | CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis |
| Q34545045 | Cancer incidence and mortality in patients with type 2 diabetes treated with human insulin: a cohort study in Shanghai |
| Q35871269 | Clinical benefits of metformin in gynecologic oncology |
| Q38226775 | Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature |
| Q89478067 | Diabetes Medication Use in Association with Survival among Patients of Breast, Colorectal, Lung, or Gastric Cancer |
| Q38000089 | Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer |
| Q34069086 | Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. |
| Q38097984 | Diabetes and cancer relationships |
| Q38195439 | Diabetes treatments and cancer risk: the importance of considering aspects of drug exposure. |
| Q37972673 | Diabetes, cancer, and metformin: connections of metabolism and cell proliferation |
| Q34392021 | Diabetes, glucose control, glucose lowering medications, and cancer risk: a 10-year population-based historical cohort |
| Q38001521 | Does use of metformin protect against cancer in Type 2 diabetes mellitus? |
| Q38558943 | Expanding the therapeutic spectrum of metformin: from diabetes to cancer. |
| Q30412619 | Exposure to excess insulin (glargine) induces type 2 diabetes mellitus in mice fed on a chow diet |
| Q26767027 | From obesity to diabetes and cancer: epidemiological links and role of therapies |
| Q47096456 | Ginkgolic acid inhibits the invasiveness of colon cancer cells through AMPK activation |
| Q34086275 | Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data. |
| Q36417868 | Insulin therapy and cancer in type 2 diabetes |
| Q51312709 | Metabolic components and recurrence in early-stage cervical cancer. |
| Q37462711 | Metabolic roles of AMPK and metformin in cancer cells |
| Q38999875 | Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation |
| Q34135248 | Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders |
| Q37837675 | Metformin and cancer: new applications for an old drug |
| Q41143859 | Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus. |
| Q52565556 | Metformin targets Mitochondrial Glycerophosphate Dehydrogenase (mGPDH) to control Rate of Oxidative Phosphorylation and growth of thyroid cancer in vitro and in vivo. |
| Q26850912 | Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review |
| Q37890687 | Metformin: a new option in cancer treatment. |
| Q57734588 | Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment |
| Q38888319 | Pharmacodynamics and Systems Pharmacology Approaches to Repurposing Drugs in the Wake of Global Health Burden |
| Q36769486 | Pre-diagnosis blood glucose and prognosis in women with breast cancer. |
| Q36282005 | Relationship between Type 2 Diabetes and Inflammation Diseases: Cohort Study in Chinese Adults |
| Q35629996 | Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity. |
| Q38005000 | Systematic review and meta-analysis of insulin therapy and risk of cancer. |
| Q64104607 | The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances |
| Q26852910 | The links between insulin resistance, diabetes, and cancer |
Search more.